人才建設

您所在的位置: 首頁 - 人才建設 - 師資隊伍 - 準聘長聘教師 - 助理教授 - 藥物研究所

藥物研究所

個人簡介

彭英,1970年生,籍貫河北唐山,中國醫學科學院藥物研究所研究員,博士生導師。1989年考入河北醫學院臨床醫學專業,1994年獲得學士學位。1996年在華西醫科大學藥理學專業攻讀碩士學位,從事藥理學研究。2001年在協和醫科大學大學藥理學專業攻讀博士學位,從事神經藥理學研究。2004年進入哈佛大學醫學院,Brigham and Women’s Hospital的神經疾病中心進行博士后研究工作,主要從事阿爾茨海默病發病機制研究。2008年回國進入藥物研究所工作,2009年聘任為副研究員。2015年聘任為研究員。


主要研究方向

腦疾病(急性缺血性腦卒中、腦外傷)的發病機制及創新藥物研究。神經退行性疾病(阿爾茨海默病、肌萎縮性側索硬化癥)的發病機制及創新藥物研究。精神疾病(焦慮癥、抑郁癥)的發病機制及創新藥物研究。


代表性成果

爆草黑丝美女|韩国19禁无遮挡啪啪无码网站|91精品国产自产精品男人的天堂|sm鞭打高潮喷水抽搐调教玩弄|果冻在线|日本大尺度吃奶呻吟视频|久久久久黄片|北条麻妃av免费观看|中文字幕一区二区人妻|亚洲最大天堂无码精品区,日韩 欧美 国产精品,国产肉丝袜在线观看,最爽无遮挡行房视频,成人H视频在线观看,糖心vlog冉冉,蜜桃产品一二三产区

1. Zhou Y#, Tang J, Lan J, Zhang Y, Wang HY, Chen QY, Kang Y, Sun Y, Feng X, Wu L, Jin HT*, Chen SZ* and Peng Y*.Honokiol alleviated neurodegeneration by reducing oxidative stress and improving mitochondrial function in mutant SOD1 cellular and mouse models of Amyotrophic lateral sclerosis. Acta Pharmaceutica Sinica B. 2022, in press. (IF=14.911)

2. Tang J#, Kang Y, Zhou Y, Li X, Lan J, Wu L, Feng X*, and Peng Y*. ALS-causing SOD1 mutants regulate occludin phosphorylation/ubiquitination and endocytic trafficking via the ITCH/Eps15/Rab5 axis. Neurobiol Dis. 2021; 153:105315. (IF=7.046)

3. Huang LJ#, Lan JQ, Tang JS, Kang YY, Feng XH, Wu L, and Peng Y*. L-3-n-Butylphthalide improves synaptic and dendritic spine plasticity and ameliorates neurites pathology in Alzheimer’s disease mouse model and cultured hippocampal neurons. Mol Neurobiol. 2021;58(3):1260-74. (IF=5.682)

4. Tang JS#, Kang YY, Huang LJ, Wu L, andPeng Y*. TIMP1 preserves the blood–brain barrier through interacting with CD63/integrin β1 complex and regulating downstream FAK/RhoA signaling. Acta Pharmaceutics Sinica B. 2020;10(6):987-1003.  (IF=11.614)

5. Huang L#, Zhang Y, Peng Y, Zhao Z, Zhou Y, Wang X*, and Peng Y*.Protective effect of potassium 2-(l-hydroxypentyl)-benzoate on hippocampal neurons, synapses and dystrophic axons in APP/PS1 mice. Psychopharmacology (Berl). 2019;236(9):2761-71. (IF= 3.13)

6. Zhao CY#, Hou WZ, Lei H, Huang LJ, Wang S, Cui DD, Xiang CH, Wang XL*, and Peng Y*. Potassium 2-(l-hydroxypentyl)-benzoate attenuates neuroinflammatory responses and upregulates heme oxygenase-1 in systemic lipopolysaccharide-induced inflammation in mice. Acta Pharmaceutica Sinica B. 2017;7(4):470-8.  (IF=6.014)

7. Li L#, Xu SF, Liu LF, Feng RT, Gong YX, Zhao XY*, Li J, Cai J, Feng N, Wang L, Wang XL*, and Peng Y*. Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer’s Disease. J Alzheimers Dis. 2017;56(4):1403-17. (IF=3.476)

8. Peng Y#, Sun J, Hon S, Nylander AN, Xia W, Feng Y, Wang X, and Lemere CA*. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease. J Neurosci. 2010;30(24):8180-9. (IF=7.271, F1000, C100)

9. Maier M#, Peng Y#, Jiang L, Seabrook TJ, Carroll MC, and Lemere CA*. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice. J Neurosci. 2008;28(25):6333-41. (IF=7.452, C100)

10. Peng Y#, Xu S, Chen G, Wang L, Feng Y, and Wang X*. L-3-n-Butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats. J Pharmacol Exp Ther. 2007;321(3):902-10. (IF=4.309, C100)